Sunny Pharmtech Pharmaceuticals is accelerating its global sales expansion. The gynecological drug CPT injectable product has seen its first shipment to the United Arab Emirates this month, with the second batch expected to be shipped by the end of the year. Additionally, there has been an increase in orders for the anti-cancer injectable CPA-I, with hopes to achieve a 15% market share this year. Next year, the company plans to enter markets outside the United States, such as Mexico. Sunny Pharmtech also revealed that a soft capsule product developed in collaboration with domestic partners will soon sign a distribution agreement in the United States. With steady growth in the first half of this year and concentrated shipments in the second half, along with contributions from milestone payments, the company expects further revenue growth.
Read more
